uniQure: Community Letter Regarding the Recent FDA Type A Meetingkatrina43841 minute ago1 min readFor ANY questions: medinfo@uniqure or 1-866-520-1257
“From Regulator to Roadblock: How FDA Bureaucracy Stifles Innovation.” The US Senate Special Committee on Aging will convene a hearing with the FDA. Submit your statement!
Community Update: Novartis development of Votoplam in HD: INVEST-HD Phase 3 trial information now available
